RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.59M | 33.74M | 30.89M | 32.61M | 30.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.59M | 33.74M | 30.89M | 32.61M | 30.34M |
| Cost of Revenue | 6.49M | 7.86M | 7.40M | 7.35M | 6.11M |
| Gross Profit | 18.10M | 25.89M | 23.50M | 25.26M | 24.23M |
| SG&A Expenses | 27.40M | 30.42M | 31.86M | 27.70M | 27.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.10M | 47.51M | 48.72M | 43.95M | 42.52M |
| Operating Income | -18.52M | -13.77M | -17.83M | -11.34M | -12.18M |
| Income Before Tax | -16.20M | -12.01M | -15.88M | -9.15M | -9.81M |
| Income Tax Expenses | 28.00K | 88.00K | 6.00K | 5.00K | 10.00K |
| Earnings from Continuing Operations | -16.22M | -12.10M | -15.88M | -9.15M | -9.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.22M | -12.10M | -15.88M | -9.15M | -9.82M |
| EBIT | -18.52M | -13.77M | -17.83M | -11.34M | -12.18M |
| EBITDA | -17.59M | -12.77M | -17.00M | -10.49M | -11.32M |
| EPS Basic | -0.39 | -0.29 | -0.38 | -0.22 | -0.24 |
| Normalized Basic EPS | -0.24 | -0.18 | -0.24 | -0.14 | -0.15 |
| EPS Diluted | -0.39 | -0.29 | -0.38 | -0.22 | -0.24 |
| Normalized Diluted EPS | -0.24 | -0.18 | -0.24 | -0.14 | -0.15 |
| Average Basic Shares Outstanding | 41.71M | 41.49M | 41.31M | 41.18M | 40.97M |
| Average Diluted Shares Outstanding | 41.71M | 41.49M | 41.31M | 41.18M | 40.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |